ANI Pharma Guides FY23 Adj. EPS Below Estimates, But Revenues Above - Update
(RTTNews) - While reporting financial results for the fourth quarter on Thursday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) initiates adjusted earnings and net revenue guidance for the full-year 2023.
For fiscal 2023, the company now projects adjusted earnings in a range of $2.09 to $2.59 per share on net revenues between $360 million and $385 million, with purified cortrophin gel revenue at $80 million to $90 million.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.62 per share on revenues of $352.49 million for the year. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use
Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) announced Monday the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.
RTTNews
|
847 days ago
ANI Pharma Says FDA Approves Methsuximide Capsules, Alendronate Sodium Oral Solution
ANI Pharmaceuticals, Inc. (ANIP) announced Monday that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Applications (ANDAs) for Methsuximide Capsules USP, 300 mg and Alendronate Sodium Oral Solution 70 mg (base)/75 mL.
RTTNews
|
1218 days ago
ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets
ANI Pharmaceuticals, Inc. (ANIP) announced Wednesday that it has received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Clorazepate Dipotassium Tablets.
RTTNews
|
1545 days ago
U.S. Dollar Advances Amid Fed Rate Hike Expectations, Fresh Crude Oil Supply Concerns
The U.S. Dollar value edged higher on Monday as investors anticipate a possible rate hike by the U.S. Federal Reserve at the end of its two-day meeting which commences tomorrow. In addition, fresh concerns of supply disruptions in the Middle East that pushed crude oil prices higher, supported the U.S. dollar.
RTTNews
|
54 minutes ago
Swiss Market Ends On Firm Note
The Switzerland market ended on a strong note on Monday after holding firm right through the day's session thanks to sustained buying at several counters.
Despite lingering concerns about geopolitical tensions and elevated oil prices, the mood in the Swiss market remained quite positive.
RTTNews
|
3h 35min ago
European Stocks Close Weak; UK Market Bucks Trend
European stocks closed weak on Monday amid concerns about rising oil prices and geopolitical tensions.
A sell-off in the tech sector following warnings of a potentially large-scale AI-driven cyberattacks hurt the markets.
RTTNews
|
3h 50min ago
Canadian Market Edges Higher On Energy Boost
Canadian market's benchmark S&P/TSX Composite Index was modestly higher a little before noon on Monday with investors digesting the nation's inflation data and assessing the potential economic impact of elevated oil prices.
RTTNews
|
6h 6min ago
Bay Street Likely To Open Weak; Inflation Data In Focus
Canadian stocks look headed for a weak start on Monday as selling is likely in the materials and technology sectors due to weak precious metals prices and warning of potentially large-scale AI-driven cyberattacks, respectively.
Energy stocks may find support as oil prices are up sharply on supply concerns.
RTTNews
|
9h 32min ago
